Read why Real-World Data is becoming a key ingredient to bring precision medecine faster and to broader sets of patients,
In this explainer video, Embleema vows to fast-track research for rare diseases
Global Head of Evidence Generation at Sanofi Discusses the Benefits of Blockchain for Pharma
Harvard Professor John Halamka Discusses the Benefits of Blockchain in Healthcare
The deal will connect Armenia to international research, in oncology, immunotherapy and molecular medicine.
The digital health revolution has made it much easier for advocacy groups to begin leveraging patient data to fast-track research and engage pharma. Here's how to do it.
In the age of precision medicine, pharma must learn to collect data directly from patients, inventing new ways to secure their buy-in, in order to roll-out a successful real-world evidence strategy.
The FDA is exploring new sources of data to assess new drugs, including from Real World Evidence : EHR, wearables, Patient Reported Outcomes. Enter Blockchain
Joint Blockchain Initiative Set to Accelerate Cancer Research and define a new ethical model in drug development.
Embleema Closes $4M Series A Funding and Joins Techstars Alchemist Blockchain Accelerator Program
Pharmagest forms Partnership with Embleema to Deploy Innovative Healthcare Blockchain Technology
From Withings to Embleema, empowering patients with digital health
Startups like Embleema Want to Help Yo Sell It
Embleema launches the first health records blockchain to give patients complete control over their health data and be at the center of clinical research.
Le RGPD s et la blockchain seraient favorables aux start-up européennes